Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

Br J Dermatol. 2007 Dec;157(6):1275-7. doi: 10.1111/j.1365-2133.2007.08205.x. Epub 2007 Oct 4.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Depressive Disorder / drug therapy*
  • Double-Blind Method
  • Etanercept
  • Fatigue / drug therapy*
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use
  • Male
  • Psoriasis / drug therapy*
  • Psoriasis / psychology
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept